"OncoSil Medical has achieved key milestones, including CE Marking, US FDA breakthrough device designation, and successful completion of the PanCO Study, demonstrating the device’s safety and efficacy. 33% of patients treated with OncoSil became eligible for surgical resection, and 57% saw at least a 50% reduction in tumour volume."
I saw the above on this article - Impressive numbers. The fact that 33% of patients became eligible for surgical resection after using OncoSil's device is a BIG deal. It shows the real-world impact this treatment is having. Plus, a 50% reduction in tumour volume for over half the patients? That is a significant achievement in the fight against pancreatic cancer.
- Forums
- ASX - By Stock
- OncoSil FDA designation & PanCO study success
"OncoSil Medical has achieved key milestones, including CE...
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.38M |
Open | High | Low | Value | Volume |
0.5¢ | 0.6¢ | 0.5¢ | $30.15K | 5.043M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 7310112 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 16635204 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 7310112 | 0.005 |
29 | 23113949 | 0.004 |
11 | 11756631 | 0.003 |
6 | 5457516 | 0.002 |
4 | 7800000 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 16635204 | 22 |
0.007 | 25918167 | 22 |
0.008 | 12043848 | 11 |
0.009 | 12462253 | 5 |
0.010 | 8693666 | 7 |
Last trade - 10.16am 05/07/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |